Immune checkpoint inhibitors and response analysis: a tough challenge. A case report

door Bearz, Alessandra, Perin, Tiziana, Cancian, Luca, Berto, Eleonora, Sartor, Ivana, Tirelli, Umberto
Gepubliceerd in BMC Res Notes (2016)

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience

door De Carlo, Elisa, Del Savio, Maria Chiara, Polesel, Jerry, Da Ros, Valentina, Berto, Eleonora, Santarossa, Sandra, Chimienti, Emanuela, Fratino, Lucia, Bearz, Alessandra
Gepubliceerd in Oncotarget (2018)

Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case report

door De Carlo, Elisa, Schiappacassi, Monica, Urbani, Martina, Doliana, Roberto, Baldassarre, Gustavo, Da Ros, Valentina, Santarossa, Sandra, Chimienti, Emanuela, Berto, Eleonora, Fratino, Lucia, Bearz, Alessandra
Gepubliceerd in Onco Targets Ther (2018)

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience

door Bearz, Alessandra, Talamini, Renato, Rossoni, Gilda, Santo, Antonio, de Pangher, Vincenzo, Fasola, Gianpiero, Rosetti, Francesco, Favaretto, Adolfo, Gregorc, Vanesa, Berretta, Massimiliano, Santarossa, Sandra, Berto, Eleonora, Tirelli, Umberto
Gepubliceerd in 2012